<DOC>
	<DOCNO>NCT00316641</DOCNO>
	<brief_summary>The purpose study determine whether Lipid-lowing Tea effective safe treatment Hyperlipidemia Patients</brief_summary>
	<brief_title>The Clinical Evaluation Efficacy Lipid-Lowing Tea Hyperlipidemia Patients ’ Lipid Profiles</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Patient age 2065 year ; either sex Patient diagnose hyperlipidemia ( fasting level TC &gt; =200mg/dL ) , TG &gt; =200mg/dL &lt; 400mg/dL , LDLC &gt; =130mg/dL ) Patient sign informed consent form Patient pregnancy ( child bear potential ) , lactation Patient lipid regulate agent within 4 week prior study period Patient currently take concomitant medication , oral contraceptive , medical treatment capable interfere lipid metabolism ( eg thiazide , βblockers , cyclosporins , itraconazole erythromycin , danazol ) Patient medical history hypothyroidism , pancreatitis , cholestasis , nephrotic syndrome , gall bladder disease , primary biliary cirrhosis . Patient liver dysfunction ( SGOT SGPT &gt; 2x ULN ) Patient renal insufficiency ( serum creatinine &gt; 1.3mg/dL ) Patient myocardial infarction , cerebrovascular disease , major operation within 6 month prior study period .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>